ADMA Biologics adds former Momenta CFO/CO Young T. Kwon to Board

ADMA BIOLOGICS, INC.

Dr. Kwon appointed as Class II director with term through 2024 annual meeting.
Previously served as CFO/CO at Momenta, leading its $6.5B sale to Johnson & Johnson in 2020.
Will receive an initial grant of options to purchase 93,500 shares of common stock.
Currently an operating partner at Lightstone Ventures, assisting with deal sourcing and portfolio management.
Brings over a decade of strategic, financial, and business development experience in biotech.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Young T. Kwon

Class II director

ADMA · ADMA BIOLOGICS, INC.

Effective: 2021-10-15
Filed: October 18, 2021, 7:59 PM ET

On October 15, 2021, the Board of Directors (the “Board”) of ADMA Biologics, Inc. (the “Company”) appointed Young T. Kwon, Ph.D. to serve on the Board as a Class II director with a term expiring at the Company’s 2024 annual meeting of stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Young T. Kwon was appointed as Class II director at ADMA BIOLOGICS, INC..

Action: appointed
Role: Class II director

Exact text from the filing

On October 15, 2021, the Board of Directors (the “Board”) of ADMA Biologics, Inc. (the “Company”) appointed Young T. Kwon, Ph.D. to serve on the Board as a Class II director with a term expiring at the Company’s 2024 annual meeting of stockholders.

View on SEC.gov

ADMA BIOLOGICS, INC. filing history →

Source: SEC EDGAR

accession 0001140361-21-034761

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.